Abstract
The current divisions in managing prescribing between primary and secondary care in the UK arise from separate budgetary arrangements. These divisions are neither sensible, organisationally efficient nor cost effective. Transition of patients across the interface of primary and secondary care has always been problematic, hindered by poor communication and coordination. Joint formularies would improve overall care and raise awareness of the need to consider overall costs within a unified National Health Service (NHS). There are, however, few examples of successful working of a joint formulary in the UK. It is likely that harmonisation of drug use in hospitals and in primary care will come about because of contracting and commissioning, and that it will largely be led by primary care, through the developing primary care groups (PCGs). Local decisions around availability and use of drug therapies will increasingly be superseded by the national decisions emanating from the newly formed National Institute for Clinical Effectiveness.
Similar content being viewed by others
References
Pearce M, Begg E. A review of limited lists and formularies: are they cost effective? Pharmacoeconomics 1992; 1: 191–202
Voss S, Hardy N, Olds T, et al. The use of practice formularies by general practitioners in Southampton and South West Hampshire. Pharma J 1997; 258: 38–40
McGavock H, Wilson Davies K, McGavock S. Formulary revision: eliciting the views of users. Br J Gen Pract 1996; 46: 419–21
Joshi M, Williams A, Petrie J. Hospital formularies in 1993: where, why and how? Pharm J 1994; 253: 63–5
Pryce AJ, Heatlie HF, Chapman SR. Buccaling under the pressure: influence of secondary care establishments on the prescribing of glyceryl trinitrate buccal tablets in primary care. BMJ 1996; 313: 1621–4
Audit Commission. A prescription for improvement. London: HMSO, 1994
Grant GB, Gregory GA, Zwanenberg TD. Development of a limited formulary for general practice. Lancet 1985; I: 1030–2
Grant GB, Gregory DA, Edwards C. A basic formulary for general practice: Oxford Medical Publications Practical guides for general practice. Oxford: Oxford University Press, 1994
Essex B. Practice formularies: towards more rational prescribing [editorial]. BMJ 1989; 298: 1052
Green P. The general practice formulary: its role in rational therapeutics. J R Coll Gen Pract 1985; 35: 570–2
Needham A, Brown M, Freeborn S. Introduction and audit of a general practice antibiotic formulary. J R Coll Gen Pract 1988; 38 (309): 166–7
Beardon P, Brown SV, Mowat DA, et al. Introducing a drug formulary to general practice: effects on practice prescribing costs. J R Coll Gen Pract 1987: 37 (300): 305–7
Hill-Smith I. Sharing resources to create a district drug formulary: a countywide controlled trial. Br J Gen Pract 1996: 46: 271–5
Dowell JS, Snadden D, Dunbar JA. Changing to generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995; 310: 505–8
Torgerson DJ, Maynard A. Fundholding and prescribing: prescribing practice may have been inefficient [letter]. BMJ 1995; 311: 128
Royal College of General Practitioners. Resource pack: how to produce a practice formulary. London: Royal College of General Practitioners, 1989
Onion C, Dutton C, Walley T, et al. Local clinical guidelines: description and evaluation of a participative method for their development and implementation. Fam Pract 1996; 13: 28–34
Wilkie P, Sibbald B, Raftery J, et al. Prescribing at the hospital-general practice interface. I: hospital outpatient dispensing policies in England. BMJ 1992; 304 (6818): 29–31
Sibbald B, Wilkie P, Raftery J, et al. Prescribing at the hospital-general practice interface. II: impact of hospital outpatient dispensing policies in England on general practitioners and hospital consultants. BMJ 1992; 304: 31–4
Crump BJ, Panton R, Drummond MF, et al. Transferring the costs of expensive treatments from secondary to primary care. BMJ 1995; 310: 509–12
National Health Service Management Executive. Responsibility for prescribing between hospitals and GPs. London: National Health Service Management Executive, 1991. Report no.: EL (91)127
Hampson JP, Roberts RI, Morgan DA. Shared care: a review of the literature. Fam Pract 1996; 13: 264–79
Evans D. A stakeholder analysis of developments at the primary and secondary care interface. Br J Gen Pract 1996; 46: 675–7
Garvey G, Jappy B, Stewart D, et al. Grampian Health Board’s joint drug formulary. BMJ 1990; 301: 851–2
Grampian formulary. Aberdeen: Drug Monitoring Unit, Aberdeen Infirmary, 1995
Lothian formulary. 3rd ed. Ediburgh: Lothian Liaison Committee, Ladywell Medical Centre, 1992
Stewart D, Milne K, Krska J, et al. Adherence to the Grampian joint drug formulary in general practice. J Clin Pharm Ther 1996; 21: 79–82
NHS in Scotland Management Executive. Management of the Drug Bill. Edinburgh: The Scottish Office, 1993. Report no.: MEL(1993)12
General Medical Services Committee. Defining core services in general practice–reclaiming professional control. London: British Medical Association, 1996
Jones R, Rawlins M. Prescribing at the interface between hospitals and general practitioners. BMJ 1992; 304: 4–5
Hunter D, Fairfield G. Disease management. BMJ 1997; 315: 50–3
National Health Service (NHS) Executive. Commercial approaches to the NHS regarding disease management packages. Leeds: NHS Executive, 1994. Report no.: EL (94)94
National Health Service (NHS) Executive. Purchasing and prescribing. Leeds: NHS Executive, 1994. Report no.: EL (94)72
Wakeman A, Leach R. Joint prescribing committees: characteristics, progress and effectiveness. Health Trends 1997; 29: 52–4
Young M, Colwill S, Spiby J. Transferring the costs of expensive treatments: guidelines may clarify responsibility for prescribing [letter]. BMJ 1995; 310: 1335
Effective Health Care Bulletin, December 1994, no. 8: implementing clinical practice guidelines. Leeds: University of Leeds, 1994. (Now from York Centre for Reviews and Dissemination)
Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465–8
Grol R. Beliefs and evidence in changing clinical practice. BMJ 1997; 315: 418–21
Purves I, Nestor G, Williams K. Testing of PRODIGY continues. BMJ 1998; 316 (7133): 776–7
British National Formulary No. 36. London: BMJ Books, 1998
Reilly A, Taylor RJ, Webster J. General practitioners’ attitudes towards the limited list. J R Coll Gen Pract 1986; 36: 151–2
Taylor RJ, Bond CM. Limited list: limited effects? BMJ 1985; 291: 518–20
Bateman, DN. The selected list. BMJ 1993; 306: 1141–2
House of Commons Select Committee. Priority setting in the NHS: the NHS drugs budget. Vol 1: report, together with an appendix and the minutes of the committee. London: HMSO, 1994
Walley T. A UK national prescribing list? Pharmacoeconomics 1995; 7: 191–202
Department of Health. The New NHS. London: HMSO, 1997
NHS Executive. A first class service: quality in the new NHS. London: HMSO, 1998
Brooks A. Viagra is licensed in Europe but rationed in Britain. BMJ 1998; 317: 765
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duerden, M., Walley, T. Prescribing at the Interface Between Primary and Secondary Care in the UK. Pharmacoeconomics 15, 435–443 (1999). https://doi.org/10.2165/00019053-199915050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199915050-00002